Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

nd of the short meeting." KNBN-TV Rapid City, SD (10/22, Murat) reports, "New developments Thursday regarding a homeless camp recently removed from Rapid City's jurisdiction, the Federal Bureau of Investigations paying the camp a visit in their new remote location. This week, the Mni Luzahan Creek Patrol se

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

eting-with-homeless-camp- leaders> Rapid City, SD (10/22, Murat) reports, "New developments Thursday regarding a homeless camp recently removed from Rapid City's jurisdiction, the Federal Bureau of Investigations paying the camp a visit in their new remote location. This week, the Mni Luzahan Creek Patrol set

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

nd of the short meeting." KNBN-TV Rapid City, SD (10/22, Murat) reports, "New developments Thursday regarding a homeless camp recently removed from Rapid City's jurisdiction, the Federal Bureau of Investigations paying the camp a visit in their new remote location. This week, the Mni Luzahan Creek Patrol se